|

Anticoagulant Oral Clinical Trials

1 actively recruiting trial

Also known as: Edoxaban, Warfarin

Pipeline

Phase 4: 1

Top Sponsors

  • Hospital Sirio-Libanes1

Indications

  • Atrium; Fibrillation1
  • Heart Disease1
  • Chronic Kidney Diseases1

Other1 trial

Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.